Federal Register Final rule: FDA is amending the animal drug regulations to reflect approval of a Cross Vetpharm Group Ltd. supplemental NADA that provides for use of a 100 mg/mL strength erythromycin injectable solution in cattle for treating bovine respiratory disease. To view this final rule, click here.
